To explain the unexplainable in MONARCH 3 overall survival: the restricted mean survival time. Letter to the Editor regarding ‘Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: Final overall survival results of MONARCH 3’ by M. P. Goetz et al
Get full text
Journal Article
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
Roila, F., Herrstedt, J., Aapro, M., Gralla, R. J., Einhorn, L. H., Ballatori, E., Bria, E., Clark-Snow, R. A., Espersen, B. T., Feyer, P., Grunberg, S. M., Hesketh, P. J., Jordan, K., Kris, M. G., Maranzano, E., Molassiotis, A., Morrow, G., Olver, I., Rapoport, B. L., Rittenberg, C., Saito, M., Tonato, M., Warr, D.
Published in Annals of oncology (01.05.2010)
Published in Annals of oncology (01.05.2010)
Get full text
Journal Article
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab
Loibl, S., Majewski, I., Guarneri, V., Nekljudova, V., Holmes, E., Bria, E., Denkert, C., Schem, C., Sotiriou, C., Loi, S., Untch, M., Conte, P., Bernards, R., Piccart, M., von Minckwitz, G., Baselga, J.
Published in Annals of oncology (01.08.2016)
Published in Annals of oncology (01.08.2016)
Get full text
Journal Article
Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis
Ciccarese, C., Iacovelli, R., Porta, C., Procopio, G., Bria, E., Astore, S., Cannella, M.A., Tortora, G.
Published in Cancer treatment reviews (01.11.2021)
Published in Cancer treatment reviews (01.11.2021)
Get full text
Journal Article
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis
Bria, E., Milella, M., Cuppone, F., Novello, S., Ceribelli, A., Vaccaro, V., Sperduti, I., Gelibter, A., Scagliotti, G.V., Cognetti, F., Giannarelli, D.
Published in Annals of oncology (01.10.2011)
Published in Annals of oncology (01.10.2011)
Get full text
Journal Article
Tracking MET de-addiction in lung cancer: A road towards the oncogenic target
Pilotto, S., Carbognin, L., Karachaliou, N., Ma, P.C., Rosell, R., Tortora, G., Bria, E.
Published in Cancer treatment reviews (01.11.2017)
Published in Cancer treatment reviews (01.11.2017)
Get full text
Journal Article
Chemotherapy Rechallenge or Reintroduction Compared to Regorafenib or Trifluridine/Tipiracil for Pretreated Metastatic Colorectal Cancer Patients: A Propensity Score Analysis of Treatment Beyond Second Line (Proserpyna Study)
Calegari, M.A., Zurlo, I.V., Dell'Aquila, E., Basso, M., Orlandi, A., Bensi, M., Camarda, F., Anghelone, A., Pozzo, C., Sperduti, I., Salvatore, L., Santini, D., Corsi, D.C., Bria, E., Tortora, G.
Published in Clinical colorectal cancer (12.06.2024)
Published in Clinical colorectal cancer (12.06.2024)
Get full text
Journal Article
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab
Loibl, S, Majewski, I, Guarneri, V, Nekljudova, V, Holmes, E, Bria, E, Denkert, C, Schem, C, Sotiriou, C, Loi, S, Untch, M, Conte, P, Bernards, R, Piccart, M, von Minckwitz, G, Baselga, J
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategies
Di Noia, V., D’Aveni, A., D’Argento, E., Rossi, S., Ghirardelli, P., Bortolotti, L., Vavassori, V., Bria, E., Ceresoli, G.L.
Published in ESMO open (01.12.2021)
Published in ESMO open (01.12.2021)
Get full text
Journal Article
Adherence to dietary guidelines (DG) and body weight change (BWC) in early-stage breast cancer (EBC): A prospective trial in patients submitted to nutrition evidence-based educational intervention
Carbognin, L., Trestini, I., Sperduti, I., Fiorio, E., Tregnago, D., Pilotto, S., Scambia, G., Tortora, G., Milella, M., Bria, E.
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
A clinical–biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status
Bria, E., De Manzoni, G., Beghelli, S., Tomezzoli, A., Barbi, S., Di Gregorio, C., Scardoni, M., Amato, E., Frizziero, M., Sperduti, I., Corbo, V., Brunelli, M., Bersani, S., Tortora, G., Scarpa, A.
Published in Annals of oncology (01.03.2013)
Published in Annals of oncology (01.03.2013)
Get full text
Journal Article
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis
Bria, E., Pilotto, S., Simbolo, M., Fassan, M., de Manzoni, G., Carbognin, L., Sperduti, I., Brunelli, M., Cataldo, I., Tomezzoli, A., Mafficini, A., Turri, G., Karachaliou, N., Rosell, R., Tortora, G., Scarpa, A.
Published in Scientific reports (10.03.2016)
Published in Scientific reports (10.03.2016)
Get full text
Journal Article
Chemotherapy rechallenge or reintroduction, regorafenib, and TAS-102 for metastatic pretreated colorectal cancer patients: a propensity score analysis of treatment beyond the second line (PROSERpINA Study)
Calegari, M., Zurlo, I., Basso, M., Orlandi, A., Bensi, M., Camarda, F., Stefano, B. Di, Vivolo, R., Pozzo, C., Sperduti, I., Bria, E., Salvatore, L., Tortora, G.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Bevacizumab (BV) maintenance after first-line chemotherapy plus BV for metastatic colorectal cancer patients: a meta-analysis of individual patients data from 3 phase III studies
Salvatore, L., Bria, E., Sperduti, I., Hinke, A., Hegewisch-Becker, S., Aparicio, T., Le Malicot, K., Boige, V., Koeberle, D., Baertschi, D., Dietrich, D., Tortora, G., Arnold, D.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Corrections to “PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab”
Loibl, S., Majewski, I., Guarneri, V., Nekljudova, V., Holmes, E., Bria, E., Denkert, C., Schem, C., Sotiriou, C., Loi, S., Untch, M., Conte, P., Bernards, R., Piccart, M., von Minckwitz, G., Baselga, J.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Major adverse cardiac events and cardiovascular toxicity with PARP inhibitors-based therapy for solid tumors: a systematic review and safety meta-analysis
Palazzo, A., Ciccarese, C., Iacovelli, R., Cannizzaro, M.C., Stefani, A., Salvatore, L., Bria, E., Tortora, G.
Published in ESMO open (01.04.2023)
Published in ESMO open (01.04.2023)
Get full text
Journal Article
Monitoring of blood serum amyloid (SAA) to predict outcome of first-line pembrolizumab (P) in patients (pts) with advanced non-small cell lung cancer (ANSCLC)
Di Noia, V., D’Argento, E., Vita, E., Ferrara, M., Damiano, P., Ribelli, M., Cannella, A., Virtuoso, A., Tortora, G., Bria, E.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab
Loibl, S, Majewski, I, Guarneri, V, Nekljudova, V, Holmes, E, Bria, E, Denkert, C, Schem, C, Sotiriou, C, Loi, S, Untch, M, Conte, P, Bernards, R, Piccart, M, von Minckwitz, G, Baselga, J
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Tubulin inhibitors in non-small cell lung cancer: looking back and forward
Ferrara, R, Pilotto, S, Peretti, U, Caccese, M, Kinspergher, S, Carbognin, L, Karachaliou, N, Rosell, R, Tortora, G, Bria, E
Published in Expert opinion on pharmacotherapy (23.05.2016)
Published in Expert opinion on pharmacotherapy (23.05.2016)
Get more information
Journal Article
Prognostic impact of nutritional support in patients affected by locally advanced or metastatic pancreatic cancer (PC) undergone chemotherapy
Trestini, I., Carbognin, L., Bonaiuto, C., Auriemma, A., Melisi, D., Salvatore, L., Sperduti, I., Bria, E., Tortora, G.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article